fbpx

Top 5 Infectious Disease Stories Week of March 2


This week, the FDA-approved antiretroviral lenacapavir as it showed treatment benefits; Oral Vancomycin Prophylaxis was explored for preventing C difficile in stem cell transplant recipients; Research into the after-effects of SARS-CoV-2 (PASC) uncovers biomarkers for post-infection sequelae; Chronic hepatitis B worsens COVID-19 outcomes, and cabotegravir ultra-long-acting (CABULA) has shown positive results.



Source link

Daily Dose of Insights

Get a daily infusion of knowledge with our latest blog updates.

We don’t spam! Read our privacy policy for more info.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Creamy Potato Soup | The Recipe Critic

This website may contain affiliate links and advertising so that we can provide recipes to you. Read...

Imdusiran for Chronic Hepatitis B Achieves Functional Cure in 50% of Patients

Arbutus Biopharma Corporation has announced breakthrough data from its IM-PROVE I Phase 2a clinical trial, demonstrating that...

Homemade Garlic Herb Seasoning | The Recipe Critic

This website may contain affiliate links and advertising so that we can provide recipes to you. Read...

Continued Reductions in Healthcare-Associated Infections

Image credit: Pexels, enginakyurtThe new fall 2024 Hospital Safety Grade report from the Leapfrog Group showed a...